Arnaud named head of Sanofi-Aventis Korea

Published: 2010-08-03 06:56:00

Updated: 2010-08-03 06:56:00

Sanofi-Aventis Korea appointed Jean-Marie Arnaud as its new chief executive, responsible for taking charge of the Korean subsidiary of the global pharmaceutical company as of August 1, 2010.

He joined Sanofi-Aventis in 1994 and worked for the firm in several Asian-Pacific countries, including ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK